Share-based Payment Arrangement, Expense in USD of BioCorRx Inc. from 2015 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
BioCorRx Inc. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from 2015 to Q3 2025.
  • BioCorRx Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $16.1K, a 45.1% decline year-over-year.
  • BioCorRx Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $203K, a 64.1% increase year-over-year.
  • BioCorRx Inc. annual Share-based Payment Arrangement, Expense for 2024 was $230K, a 259% increase from 2023.
  • BioCorRx Inc. annual Share-based Payment Arrangement, Expense for 2023 was $63.9K, a 42.4% decline from 2022.
  • BioCorRx Inc. annual Share-based Payment Arrangement, Expense for 2022 was $111K, a 1175% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

BioCorRx Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $203K $16.1K -$13.2K -45.1% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025
Q2 2025 $216K $30.7K +$235 +0.77% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 $216K $35.1K -$13.4K -27.6% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025
Q4 2024 $230K $121K +$106K +673% 01 Oct 2024 31 Dec 2024 10-K 31 Mar 2025
Q3 2024 $124K $29.3K +$13.1K +80.6% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025
Q2 2024 $111K $30.5K +$14.5K +91.1% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025
Q1 2024 $96.3K $48.5K +$32.4K +201% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025
Q4 2023 $63.9K $15.7K -$3.67K -18.9% 01 Oct 2023 31 Dec 2023 10-K 31 Mar 2025
Q3 2023 $67.6K $16.2K -$7.12K -30.5% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024
Q2 2023 $74.7K $16K +$458 +2.96% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024
Q1 2023 $74.3K $16.1K -$36.8K -69.6% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024
Q4 2022 $111K $19.4K +$19.4K 01 Oct 2022 31 Dec 2022 10-K 01 Apr 2024
Q3 2022 $91.7K $23.3K +$23.3K 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023
Q2 2022 $68.4K $15.5K +$11.8K +320% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 $56.6K $52.9K +$47.9K +952% 01 Jan 2022 31 Mar 2022 10-Q 16 May 2022
Q4 2021 $8.72K $0 -$11K -100% 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2023
Q3 2021 $19.7K $0 -$7.83K -100% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 $27.5K $3.69K -$5.52K -59.9% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022
Q1 2021 $33K $5.03K -$43.7K -89.7% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022
Q4 2020 $76.8K $11K -$18.1K -62.2% 01 Oct 2020 31 Dec 2020 10-K 31 Mar 2022
Q3 2020 $94.8K $7.83K -$3.86K -33% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021
Q2 2020 $98.7K $9.2K -$694K -98.7% 01 Apr 2020 30 Jun 2020 10-Q 13 Aug 2021
Q1 2020 $793K $48.8K -$902K -94.9% 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021
Q4 2019 $1.69M $29K -$1.21M -97.7% 01 Oct 2019 31 Dec 2019 10-K 31 Mar 2021
Q3 2019 $2.91M $11.7K -$939K -98.8% 01 Jul 2019 30 Sep 2019 10-Q 16 Nov 2020
Q2 2019 $3.85M $703K +$625K +795% 01 Apr 2019 30 Jun 2019 10-Q 14 Aug 2020
Q1 2019 $3.22M $951K +$872K +1111% 01 Jan 2019 31 Mar 2019 10-Q 15 May 2020
Q4 2018 $2.35M $1.24M +$1.16M +1481% 01 Oct 2018 31 Dec 2018 10-K 30 Mar 2020
Q3 2018 $1.19M $951K +$867K +1034% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019
Q2 2018 $319K $78.5K -$1 0% 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019
Q1 2018 $319K $78.5K $0 0% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019
Q4 2017 $319K $78.5K $0 0% 01 Oct 2017 31 Dec 2017 10-K 16 Apr 2019
Q3 2017 $319K $83.9K +$5.32K +6.77% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018
Q2 2017 $314K $78.5K +$52.4K +200% 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018
Q1 2017 $262K $78.5K +$78.5K 01 Jan 2017 31 Mar 2017 10-Q 15 May 2017
Q4 2016 $183K $78.5K 01 Oct 2016 31 Dec 2016 10-K 13 Apr 2017
Q3 2016 $78.5K 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017
Q2 2016 $26.2K 01 Apr 2016 30 Jun 2016 10-Q 11 Aug 2017
Q1 2016 $0 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017

BioCorRx Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $230K +$166K +259% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025
2023 $63.9K -$47.1K -42.4% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025
2022 $111K +$102K +1175% 01 Jan 2022 31 Dec 2022 10-K 01 Apr 2024
2021 $8.72K -$68K -88.6% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023
2020 $76.8K -$1.62M -95.5% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022
2019 $1.69M -$655K -27.9% 01 Jan 2019 31 Dec 2019 10-K 31 Mar 2021
2018 $2.35M +$2.03M +635% 01 Jan 2018 31 Dec 2018 10-K 30 Mar 2020
2017 $319K +$136K +74.3% 01 Jan 2017 31 Dec 2017 10-K 16 Apr 2019
2016 $183K +$2.71K +1.5% 01 Jan 2016 31 Dec 2016 10-K 13 Apr 2017
2015 $181K 01 Jan 2015 31 Dec 2015 10-K 13 Apr 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.